{"id":"https://openalex.org/W962596978","doi":null,"title":"Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.","display_name":"Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-05-01","ids":{"openalex":"https://openalex.org/W962596978","mag":"962596978","pmid":"https://pubmed.ncbi.nlm.nih.gov/9684137"},"language":"en","primary_location":{"id":"pmid:9684137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9684137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepato-gastroenterology","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W962596978"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112170733","display_name":"Claus Niederau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44260953","display_name":"Heinrich Heine University D\u00fcsseldorf","ror":"https://ror.org/024z2rq82","country_code":"DE","type":"education","lineage":["https://openalex.org/I44260953"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C Niederau","raw_affiliation_strings":["Department of Medicine, Heinrich-Heine-University of D\u00fcsseldorf, Germany. claus.niederau@uni-duesseldorf.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Heinrich-Heine-University of D\u00fcsseldorf, Germany. claus.niederau@uni-duesseldorf.de","institution_ids":["https://openalex.org/I44260953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019520044","display_name":"Georg W. Strohmeyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Strohmeyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073812582","display_name":"Tobias Heintges","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Heintges","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108214127","display_name":"Kristiina Peter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Peter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014122995","display_name":"Ernst G\u00f6pfert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E G\u00f6pfert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6354,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.89857856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"45","issue":"21","first_page":"797","last_page":"804"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyunsaturated-phosphatidylcholine","display_name":"polyunsaturated phosphatidylcholine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8880000114440918},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8299999833106995},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.6259999871253967},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/hbeag","display_name":"HBeAg","score":0.45500001311302185},{"id":"https://openalex.org/keywords/hbv-dna","display_name":"HBV DNA","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hcv-rna","display_name":"HCV RNA","score":0.9419999718666077},{"id":"https://openalex.org/keywords/liver-biopsy-histopathology","display_name":"liver biopsy histology","score":0.41200000047683716},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.814427375793457},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7788639068603516},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.7044570446014404},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6916942596435547},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.5404196381568909},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.494064599275589},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.4793142080307007},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.4684344232082367},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.4457618296146393},{"id":"https://openalex.org/C2777766500","wikidata":"https://www.wikidata.org/wiki/Q360841","display_name":"Liver biopsy","level":3,"score":0.4307108223438263},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41230112314224243},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41026610136032104},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3647037744522095},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.17598402500152588},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13903969526290894},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.11846494674682617},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006521","descriptor_name":"Hepatitis, Chronic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9684137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9684137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepato-gastroenterology","raw_type":"Clinical Trial"},{"id":"mag:962596978","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9684137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2384430474","https://openalex.org/W2355845197","https://openalex.org/W2329529440","https://openalex.org/W2147562981","https://openalex.org/W2050863339","https://openalex.org/W2413517600","https://openalex.org/W1834213368","https://openalex.org/W4283262044","https://openalex.org/W2419560152","https://openalex.org/W2368655454"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"Polyunsaturated":[1],"phospatidyl-choline":[2],"(PPC)":[3],"has":[4],"been":[5],"shown":[6],"to":[7,100,127,244,253,287,328,347],"reduce":[8,329],"serum":[9,52],"aminotransferases":[10],"in":[11,25,33,171,176,189,200,215,217,227,233,263,271,289,311,317,326],"experimental":[12],"hepatitis.":[13],"This":[14],"multi-center,":[15],"randomized,":[16],"double-blind,":[17],"placebo-controlled":[18],"trial":[19],"evaluated":[20],"the":[21,60,165,172,177,212,228,234,247,255,272,284,330],"effects":[22],"of":[23,43,63,108,118,134,140,153,191,202,223,249,257,299,324],"PPC":[24,109,158,173,210,229,241,280,294,307,334,353],"patients":[26,163,192,203,218,225,264,290,312,340],"with":[27,35,104,156,196,219,265,291,313,319,341],"chronic":[28,44,68,314,342],"hepatitis":[29,46,69,220,266,292,315,343],"B":[30],"and":[31,67,82,96,174,302,321,349,359],"C":[32,267,316],"combination":[34,318],"interferon":[36,88,154,250,288,320,325],"alpha":[37],"2a":[38],"or":[39,115,159],"2b.":[40],"The":[41,143],"diagnosis":[42],"viral":[45,65],"was":[47,129,187],"based":[48],"on":[49,71],"an":[50],"abnormal":[51],"alanine":[53],"aminotransferase":[54],"(ALT)":[55],"value":[56,62],"(more":[57],"than":[58,138],"twice":[59],"upper":[61],"normal),":[64],"replication":[66],"found":[70],"liver":[72],"biopsy.":[73],"METHODOLOGY:":[74],"Patients":[75],"received":[76,205],"5":[77],"million":[78,84],"I.U.":[79,85],"(Hepatitis":[80],"B)":[81],"3":[83],"(hepatitis":[86],"C)":[87],"s.c.":[89],"thrice":[90],"weekly":[91],"for":[92,122,147,339],"24":[93,123,149],"weeks,":[94],"respectively,":[95],"were":[97,145,194],"randomly":[98],"assigned":[99],"additional":[101],"oral":[102],"medication":[103],"either":[105,157],"6":[106,116],"capsules":[107,117],"(total":[110],"daily":[111],"dose:":[112],"1.8":[113],"g)":[114],"placebo":[119,178,206,235],"per":[120],"day":[121],"weeks.":[124],"Biochemical":[125],"response":[126,182,213,286],"therapy":[128,155,242,251],"defined":[130],"as":[131],"a":[132],"reduction":[133],"ALT":[135,185],"by":[136],"more":[137],"50%":[139,184],"pre-treatment":[141],"values.":[142],"responders":[144,245,259],"treated":[146,195],"further":[148],"weeks":[150],"after":[151,322],"cessation":[152,248],"placebo.":[160],"RESULTS:":[161],"176":[162],"completed":[164],"study":[166],"protocol":[167],"(per-protocol":[168],"population:":[169],"92":[170],"84":[175],"group).":[179],"A":[180],"biochemical":[181,285],"(>":[183],"reduction)":[186],"seen":[188],"71%":[190,222],"who":[193,204],"PPC,":[197],"but":[198],"only":[199],"56%":[201],"(p":[207,237],"<":[208,238],"0.05).":[209,239],"increased":[211],"rate":[214,256],"particular":[216],"C:":[221],"those":[224],"responded":[226],"group":[230,236],"versus":[231,269],"51%":[232],"Prolonged":[240],"given":[243],"beyond":[246],"tended":[252],"increase":[254],"sustained":[258],"at":[260],"week":[261],"48":[262],"(41%":[268],"15%":[270],"control":[273],"group;":[274],"p":[275],"=":[276],"0.064).":[277],"In":[278,305,345],"contrast,":[279],"did":[281,295],"not":[282,296,336,355],"alter":[283],"B.":[293,344],"accelerate":[297],"elimination":[298],"HBV-DNA,":[300],"HBeAg":[301],"HCV-RNA.":[303],"CONCLUSIONS:":[304],"conclusion,":[306],"may":[308,335],"be":[309,337],"recommended":[310,338],"termination":[323],"order":[327],"high":[331],"relapse":[332],"rate.":[333],"contrast":[346],"IFN":[348],"other":[350],"antiviral":[351],"agents":[352],"does":[354],"carry":[356],"major":[357],"risks":[358],"is":[360],"tolerated":[361],"very":[362],"well.":[363]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W962596978","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
